Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Imago BioSciences, Inc. IMGO
$36.01
На 18:04, 12 мая 2023
-0.03%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
36.09
-
week52low
11.56
-
Revenue
0
-
P/E TTM
-20
-
Beta
0.00000000
-
EPS
0.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 ноя 2022 г. в 01:44
Описание компании
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 16 авг 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 25 мар 2022 г. |
| HC Wainwright & Co. | Buy | 14 февр 2022 г. | |
| Stifel | Buy | 10 авг 2021 г. | |
| Jefferies | Buy | 10 авг 2021 г. | |
| Wedbush | Outperform | 28 окт 2022 г. | |
| Jefferies | Hold | Buy | 22 ноя 2022 г. |
| HC Wainwright & Co. | Neutral | Buy | 22 ноя 2022 г. |
| Cowen & Co. | Market Perform | Outperform | 22 ноя 2022 г. |
| Wedbush | Neutral | Outperform | 21 ноя 2022 г. |
| Stifel | Hold | Buy | 28 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| KEATING LAURIE | D | 0 | 11904 | 11 янв 2023 г. |
| Tapper Amy E. | D | 0 | 103000 | 11 янв 2023 г. |
| Tapper Amy E. | D | 0 | 141094 | 11 янв 2023 г. |
| Kariuki Enoch | D | 0 | 11904 | 11 янв 2023 г. |
| Arenberg Michael | D | 0 | 304206 | 11 янв 2023 г. |
| Arenberg Michael | D | 0 | 51532 | 11 янв 2023 г. |
| HENNER DENNIS | D | 0 | 11904 | 11 янв 2023 г. |
| HENNER DENNIS | D | 0 | 26095 | 11 янв 2023 г. |
| Eichorn Laura G. | D | 0 | 103000 | 11 янв 2023 г. |
| Eichorn Laura G. | A | 0 | 246453 | 11 янв 2023 г. |
Новостная лента
These Were the 5 Best and Worst Performing Small-Cap Stocks in November 2022
24/7 Wall Street
13 дек 2022 г. в 22:55
Investing in small-cap stocks is usually a very risky business, but they could offer quick and hefty returns.
Imago BioSciences: The Bone Marrow Cancer Researcher Reaches Milestone
Seeking Alpha
30 ноя 2022 г. в 16:07
Imago BioSciences becomes part of the Merck & Co., Inc. family for $1.35 billion. Imago BioSciences, Inc. will certainly strengthen Merck's position in hematology.
Imago (IMGO) Shares Surge 104% on Buyout Offer From Merck
Zacks Investment Research
22 ноя 2022 г. в 14:18
Imago BioSciences (IMGO) to be acquired by pharma-giant Merck (MRK) for $1.35 billion. The transaction is likely to close by first-quarter 2023.
Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout
Investors Business Daily
21 ноя 2022 г. в 09:55
Biotech stock Imago BioSciences broke out and hit a record high Monday after Merck pledged to buy it for $1.35 billion. The post Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout appeared first on Investor's Business Daily.
Merck Making Moves, to Acquire Imago Biosciences
Schaeffers Research
21 ноя 2022 г. в 09:05
Merck & Co., Inc. (NYSE:MRK) is set to acquire biopharmaceutical company Imago Biosciences Inc (NASDAQ:IMGO) in a cash deal worth $1.35 billion.